4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000004
Options or other derivatives
- Chief Operating Officer acquired 2,198,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Parikh Anand Kiran Chief Operating Officer | 2026-02-17 | Grant or award · Series B Preferred Stock | +809,822 | 809,822 | D | ||
| Parikh Anand Kiran Chief Operating Officer | 2026-02-17 | Grant or award · Employee Stock Option (right to buy) | +92,533 | 92,533 | D | ||
| Parikh Anand Kiran Chief Operating Officer | 2026-02-17 | Grant or award · Employee Stock Option (right to buy) | +56,673 | 56,673 | D | ||
| Parikh Anand Kiran Chief Operating Officer | 2026-02-19 | Grant or award · Employee Stock Option (right to buy) | +1,239,305 | 1,239,305 | D | ||
Loading xslF345X05/form4-02202026_020201.xml…